Artificial Intelligence powered breast ultrasound

Research image, courtesy of POSTECH. 


March 10, 2023 — Breast cancer undisputedly has the highest incidence rate in female patients. Moreover, out of the six major cancers, it is the only one that has shown an increasing trend over the past 20 years. The chance of survival would be higher if breast cancer is detected and treated early. However, the survival rate drastically decreases to less than 75% after stage 3, which means early detection with regular medical check-ups is critical for reducing patient mortality. . Recently a research team at POSTECH developed an AI network system for ultrasonography to accurately detect and diagnose breast cancer. 

A team of researchers from POSTECH led by Professor Chulhong Kim (Department of Convergence IT Engineering, the Department of Electrical Engineering, and the Department of Mechanical Engineering), and Sampa Misra and Chiho Yoon (Department of Electrical Engineering) has developed a deep learning-based multimodal fusion network for segmentation and classification of breast cancers using B-mode and strain elastography ultrasound images. The findings from the study were published in Bioengineering & Translational Medicine. 

Ultrasonography is one of the key medical imaging modalities for evaluating breast lesions. To distinguish benign from malignant lesions, computer-aided diagnosis (CAD) systems have offered radiologists a great deal of help by automatically segmenting and identifying features of lesions. 

Here, the team presented deep learning (DL)-based methods to segment the lesions and then classify them as benign or malignant, using both B-mode and strain elastography (SE-mode) images. First of all, the team constructed a ‘weighted multimodal U-Net (W-MM-U-Net) model’ where the optimum weight is assigned on different imaging modalities to segment lesions, utilizing a weighted-skip connection method. Also, they proposed a ‘multimodal fusion framework (MFF)’ on cropped B-mode and SE-mode ultrasound (US) lesion images to classify benign and malignant lesions. 

The MFF consists of an integrated feature network (IFN) and a decision network (DN). Unlike other recent fusion methods, the proposed MFF method can simultaneously learn complementary information from convolutional neural networks (CNN) that are trained with B-mode and SE-mode US images. The features of the CNN are ensembled using the multimodal EmbraceNet model, while DN classifies the images using those features. 

The method predicted seven benign patients as being benign in three out of the five trials and six malignant patients as being malignant in five out of the five trials, according to the experimental results on the clinical data. This means the proposed method outperforms the conventional single and multimodal methods and would potentially enhance the classification accuracy of radiologists for breast cancer detection in US images. 

Professor Chulhong Kim explained, “We were able to increase the accuracy of lesion segmentation by determining the importance of each input modal and automatically giving the proper weight.” He added, “We trained each deep learning model and the ensemble model at the same time to have a much better classification performance than the conventional single modal or other multimodal methods.” 

This study was conducted with the support from the Ministry of Science and ICT, the Ministry of Education, and the Electronics and Telecommunications Research Institute (ETRI) of Korea. 

For more information: https://international.postech.ac.kr/ 


Related Content

News | Stroke

Dec. 18, 2025 — Brainomix, a provider of AI-powered imaging biomarkers for stroke and lung fibrosis, has announced ...

Time December 24, 2025
arrow
News | Focused Ultrasound Therapy

Dec. 19, 2025 — Washington University in St. Louis (WashU) has been recognized as a Focused Ultrasound Center of ...

Time December 23, 2025
arrow
News | Information Technology

Dec. 16, 2025 — McCrae Tech has launched the world’s first health AI orchestrator called Orchestral. It is a health ...

Time December 23, 2025
arrow
News | Women's Health

Dec. 12. 2025 — A new study has found that an individualized approach to breast cancer screening that assesses patients’ ...

Time December 17, 2025
arrow
News | RSNA 2025

Dec. 12, 2025 — At RSNA 2025, United Imaging Intelligence (UII), the AI-focused subsidiary of United Imaging Group ...

Time December 17, 2025
arrow
News | Breast Imaging

Dec. 16, 2025 — Hologic, Inc, a medical technology company dedicated to improving women’s health, recently announced new ...

Time December 16, 2025
arrow
News | Artificial Intelligence

Dec. 1, 2025 — Researchers at the University of California, Berkeley and University of California, San Francisco have ...

Time December 10, 2025
arrow
Feature | Radiation Oncology | Kyle Hardner

Genomics has guided personalized cancer treatments for the past two decades. Now, AI biomarkers are expanding the field ...

Time December 09, 2025
arrow
News | Breast Imaging

Dec. 01, 2025 — DeepHealth, a wholly owned subsidiary of RadNet, Inc., has launched the DeepHealth Breast Suite,2 an end ...

Time December 04, 2025
arrow
News | Women's Health

Dec. 1, 2025 — ScreenPoint Medical has completed a commercial agreement making its Transpara breast-imaging AI portfolio ...

Time December 03, 2025
arrow
Subscribe Now